NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors

Conditions

• Solid Tumor
• Hepatocellular Carcinoma
• Colorectal Cancer
• Glioma

Interventions

• DRUG: KD-025 CAR-T cells

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Collaborators

• [object Object]